110 related articles for article (PubMed ID: 7032118)
1. [Immunologic monitoring in allogeneic bone marrow transplantation].
Serova LD; Voĭtenko LM; Mishina LV; Shabalin VN
Vestn Akad Med Nauk SSSR; 1981; (10):57-62. PubMed ID: 7032118
[No Abstract] [Full Text] [Related]
2. [T and B lymphocytes in bone marrow suppression].
Pecka M; Bláha M; Procházková J; Marecek D; Jebavý L; Malý J
Vnitr Lek; 1985 Jun; 31(6):560-6. PubMed ID: 3875925
[No Abstract] [Full Text] [Related]
3. [Studies on immune status of allogeneic bone marrow-transplanted patients. I. Imbalance of T-cell subsets].
Kai S; Hara H; Nagai K; Ifuku H; Misawa M; Fujita S
Rinsho Ketsueki; 1982 May; 23(5):643-50. PubMed ID: 6752483
[No Abstract] [Full Text] [Related]
4. Immunologic mechanisms in aplastic anemia.
Finlay JL; Ershler WB; Shahidi NT
Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
[TBL] [Abstract][Full Text] [Related]
5. [T- and B-lymphocyte content in aplastic anemia].
Sarnitskiĭ IP; Tishchenko LM; Dadaian OA
Vrach Delo; 1981 Jan; (1):52-5. PubMed ID: 6971016
[No Abstract] [Full Text] [Related]
6. Treatment of severe aplastic anemia with a prolonged course of anti-thymocyte globulin.
Cosimi AB; Peters C; Harmon D; Ellman L
Transplant Proc; 1982 Dec; 14(4):761-4. PubMed ID: 6984802
[No Abstract] [Full Text] [Related]
7. [Role of immunologic mechanisms in aplastic anemia].
Górski A
Acta Haematol Pol; 1978; 9(4):269-72. PubMed ID: 367032
[No Abstract] [Full Text] [Related]
8. [Immunological mechanisms in aplastic anemia. II. Clinical data suggesting the role of immunologic disorders in the etiology of aplastic anemia: studies in vitro].
Rupniewska ZM; Dmoszyńska-Giannopoulos A
Przegl Lek; 1982; 39(10):667-74. PubMed ID: 6218514
[No Abstract] [Full Text] [Related]
9. [B and T lymphocyte subpopulations in peripheral blood and bone marrow blood from aplastic anemia in childhood (author's transl)].
Nakagawa T; Yata J; Nakayama K
Rinsho Ketsueki; 1975 Sep; 16(9):850-8. PubMed ID: 175190
[No Abstract] [Full Text] [Related]
10. [Transfusion of allogeneic bone marrow in hypo- and aplastic anemia].
Bogoiavlenskaia MP; Frinovskaia IV; Orlov GP; Kochemasov VV; Liubimova LS
Probl Gematol Pereliv Krovi; 1975 Dec; 20(12):23-8. PubMed ID: 781662
[No Abstract] [Full Text] [Related]
11. [Immunomodulating treatment of severe aplastic anemia in adults].
Tangen JM; Wisløff ; Andersen OK
Tidsskr Nor Laegeforen; 1993 Apr; 113(11):1351-4. PubMed ID: 8337623
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation can restore CD4+ T-lymphocyte count and immune function in idiopathic CD4+ T-lymphocytopenia.
Petersen EJ; Rozenberg-Arska M; Dekker AW; Clevers HC; Verdonck LF
Bone Marrow Transplant; 1996 Oct; 18(4):813-5. PubMed ID: 8899203
[TBL] [Abstract][Full Text] [Related]
13. The significance of immunological monitoring after allogeneic bone marrow transplantation.
Pavletić Z; Petrovecki M; Bogdanić V; Nemet D; Uzarević B; Matek Z; Marković J; Marusić M; Labar B
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():111. PubMed ID: 2627597
[No Abstract] [Full Text] [Related]
14. Immunological monitoring of bone marrow transplantation.
Voltarelli JC; Stites DP
Diagn Immunol; 1986; 4(4):171-93. PubMed ID: 3530598
[No Abstract] [Full Text] [Related]
15. Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation Group.
Bacigalupo A
Eur J Haematol Suppl; 1996; 60():16-9. PubMed ID: 8987236
[TBL] [Abstract][Full Text] [Related]
16. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
[TBL] [Abstract][Full Text] [Related]
17. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.
Roychowdhury DF; Linker CA
Bone Marrow Transplant; 1995 Sep; 16(3):471-2. PubMed ID: 8535322
[TBL] [Abstract][Full Text] [Related]
18. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
Bacigalupo A; Valle M; Podestà M; Pitto A; Zocchi E; De Flora A; Pozzi S; Luchetti S; Frassoni F; Van Lint MT; Piaggio G
Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
[TBL] [Abstract][Full Text] [Related]
20. [The effect of transplantation of homologous freshly-prepared bone marrow on the course of hypoplastic and aplastic anemias].
Faĭnshteĭn FE; Turbina NS; Frinovskaia IV; Zotikov EA; Rozanova NS
Probl Gematol Pereliv Krovi; 1967 Dec; 12(12):3-8. PubMed ID: 4894325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
